Open company graph database — free web & API
ログイン

PCI Pharma Services

銘柄コード
—
上場市場
—
国
—
従業員(単独)
—
関連会社
0
§01

基本情報

BASIC
所在地
出典
社長
Michelle Logan出典
従業員数(単独)
従業員数(連結)
開始日
終了日
§02

サイト

1 DOMAINS
§03

事業内容

50
Sterile Clinical Trial Services出典Advanced Drug Delivery & Drug-Device Combination Products出典Commercial Packaging Technology出典Clinical Trial Services出典Development of Sterile Formulations出典Lyophilization Cycle Development出典Sterile Manufacturing出典Sterile Fill-Finish & Lyophilization出典Bulk Lyophilization出典Prefilled Syringe Services出典Complex Formulations出典Quality & Regulatory Services (QRS)出典Sterile Services出典Non-Sterile Services出典Drug-Device Combination Products出典Cold Chain Packaging & Labeling出典Biologics Packaging出典Compliance & Adherence Packaging出典Packaging Design & Development出典Storage, Distribution & Returns出典clinicalSMART™出典Clinical Support Services出典Our Client Platform - pci | bridge™出典Advanced Drug Delivery Systems出典Standard & Specialty Dosage Forms出典Launch & New Product Introduction出典Serialization & Anti-Counterfeiting出典Pharmaceutical Development出典High-Potent Drug Development出典Oral Targeted Therapies出典High-Potent Manufacturing出典High-Potent Clinical Manufacturing出典High-Potent Commercial Manufacturing出典Activ-Blister™ Solutions出典Temperature Controlled Packaging出典pharmaceutical supply chain services出典Clinical出典Commercial出典Development and Manufacturing出典biotech capabilities出典Advanced Drug Delivery (ADD)出典drug product capabilities across sterile and non-sterile dosage forms出典clinical trial services出典supply chain management出典clinical packaging出典labeling出典cold chain logistics出典manufacture-to-market solution出典development and manufacturing出典commercial packaging technology出典
§04

関連会社

0 COMPANIES

—

§05

関連図

NETWORK
ドラッグで移動 · クリックで詳細へ
§07

ニュース

6 ARTICLES

PCI Expands U.S. Sterile Manufacturing出典

PCI Pharma Services announced major U.S. infrastructure investments exceeding $1 billion to expand its sterile fill-finish and drug-device combination capabilities. Plans include high-speed isolator filling lines for prefilled syringes, cartridges and vials, as well as drug-device combination assembly and packaging.

PCI Pharma Services Secures Strategic Investment出典

PCI Pharma Services announced a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, with significant reinvestment from Mubadala. The transaction also includes continued investment from Partners Group and is intended to accelerate PCI’s position in the CDMO sector.

Bedford Facility Update出典

PCI Pharma Services will introduce its new 50,000-square-foot sterile fill-finish facility at its Bedford, New Hampshire campus during the BIO International Convention, June 16–19, in Boston. Construction and infrastructure installation are complete, and qualification activities are underway as the facility approaches full-scale GMP production this summer.

PCI Completes Ajinomoto Althea Acquisition出典

PCI Pharma Services announced it has completed its acquisition of Ajinomoto Althea. The acquisition is part of PCI’s $1 billion investment strategy and enhances its U.S. drug product manufacturing for aseptic filling of prefilled syringes and cartridges. It also furthers PCI’s growth in sterile fill-finish, advanced drug delivery systems and biologics.

PCI to Acquire Ajinomoto Althea出典

PCI Pharma Services announced it is acquiring the entire equity stake in US-based sterile fill-finish CDMO Ajinomoto Althea. The acquisition will create a large-scale manufacturing hub in the San Diego region, adding aseptic facilities for prefilled syringes, cartridges and high-potency formulations such as ADCs.

PCI Pharma & ChiRhoClin Secure Pancreatic Drug出典

PCI Pharma Services has partnered with ChiRhoClin, Inc. to prevent a shortage of the critical orphan diagnostic drug ChiRhoStim® used for pancreatic disease and cancer testing. The collaboration, completed on a tight schedule, ensures a stable supply of the drug across the United States, benefiting patients nationwide.

§09

出典・更新

SOURCES
↑